학술논문

Guadecitabine vs TC in relapsed/refractory AML after intensive chemotherapy: a randomized phase 3 ASTRAL-2 trial
Document Type
Article
Source
In: Blood Advances. (Blood Advances, 23 April 2024, 8(8):2020-2029)
Subject
Language
English
ISSN
24739537
24739529